GLP-1 receptor agonists in dementia

MYPI2025002042A0Undetermined Publication Date: 2021-05-06NOVO NORDISK AS
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025002042
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-07-20
Filing Date
2020-11-05
Publication Date
2021-05-06
Patent Text Reader

Abstract

The present invention relates to improved medical therapies for all forms and stages of dementia involving administration of (i) GLP-1 receptor agonists to subjects with metabolic syndrome or (ii) semaglutide.
Need to check novelty before this filing date? Find Prior Art